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Abstract 
Background: Rash impulsiveness, the propensity for approach behaviour despite potential 
negative consequences, is associated with stronger alcohol craving in patients with Alcohol 
Use Disorder (AUD). This relationship is poorly understood and implications for treatment 
response unexamined. This study explored the relationship between rash impulsiveness, 
craving, and treatment response in a sample of AUD outpatients.  
Design: Longitudinal study conducted over a 12-week intervention period.  
Setting: University public hospital outpatient alcohol and drug clinic.  
Participants: Patients attending an abstinence-based Cognitive-Behavioural Therapy program 
for AUD (N = 304).  
Procedure: Assessments were completed pre-and-post treatment. Craving and alcohol 
consumption were assessed at each treatment session.  
Results: Higher rash impulsiveness predicted more frequent craving over treatment (b = 0.95, 
95% CI = 0.40, 1.50). Higher craving was associated with greater lapse-risk (b = 0.04, 95% 
CI = 0.03, 0.05). The association between craving and lapse-risk increased as treatment 
progressed (b = 0.01, 95% CI = 0.01, 0.02). Craving positively mediated the relationship 
between impulsivity and lapse-risk (µ = 0.38, 95% CI = 0.10, 0.70).  
Conclusions: Craving mediates the effect of impulsivity in the prediction of lapse during 
abstinence-oriented treatment for AUD. Frequent assessment and management of craving 
during treatment is recommended to reduce alcohol lapse.  
 
Key words: alcohol; rash impulsiveness; craving; Cognitive-Behavioural Therapy; treatment 
response 
Manuscript Word Count: 3477  
Page 3 of 29 
 
Introduction 
Alcohol Use Disorder (AUD) is a chronic relapsing condition among those who are 
severely dependent 1,2. Several cognitive and behavioural treatments with strong empirical 
support are available, though no single approach has demonstrated superiority 3,4. Research 
attention has shifted from the development of new interventions towards identifying the 
effective components of current treatments; specifically, what works for whom 5–8. To 
achieve this goal predictors of treatment outcome must be identified 9 and the mechanisms 
that affect differential treatment response must be understood 5,10. Alcohol craving and 
impulsivity have been independently related to treatment response and identified as potential 
targets within personalised interventions 8. Recent research has found evidence of an 
association between impulsivity and alcohol craving 11–14. This may have important 
implications in AUD maintenance and treatment response. 
Craving is considered a subjective desire to use a substance and is prominent among 
those that are substance dependent 15,16. The experience of craving can include physiological 
discomfort, intrusive substance-related cognitions, and affective distress 15,16. Craving is a 
dynamic state, variable in intensity, frequency, and duration 17. It may be induced by 
physiological, cognitive, affective, or environmental cues 18. Temptation to drink arises from 
the belief that alcohol will alleviate craving-related distress 16. Craving is a widely recognised 
symptom of substance dependence informing diagnosis and treatment prognosis 8,15,19,20. 
Craving management is a central component of AUD interventions, with most addiction 
services considering craving in treatment planning 21.  
Impulsivity, as it pertains to addiction, may be best represented by two core 
processes: (i) a heightened sensitivity to rewarding stimuli increasing the motivation to 
approach drugs (Reward Sensitivity/Drive); and (ii) a propensity for approach behaviour in 
spite of negative future consequences (Rash Impulsiveness) 22–25. Reward drive has 
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similarities to Sensation Seeking in some models of impulsivity 26 and (agentic) Extraversion 
22. Rash impulsiveness is closely aligned with Zuckerman’s Impulsive Sensation Seeking 27, 
(Lack of) Premeditation 26, and Barratt’s Impulsiveness 28. Both reward drive and rash 
impulsiveness are considered personality traits which are relatively stable over time. Where 
reward sensitivity is a robust predictor of constructs pertaining to alcohol approach 
behaviours 29–32, including cue-elicited urge to drink 12–14, rash impulsiveness is more heavily 
implicated in problematic use and Substance Use Disorders (SUDs) 25,33. 
Rash impulsiveness is predictive of the onset of SUDs 33, higher levels of 
consumption 25, greater risk of lapse during treatment 34, and higher likelihood of relapse 
post-treatment 11,35. Rash impulsiveness may moderate reward sensitivity in occasions of 
problem use, causing greater issue within treatment populations. This is consistent with 
neurobiological models of addiction, maintaining that while incentive salience arises from the 
limbic system, subsequent approach behaviour is determined by ‘executive’ prefrontal 
inhibitory systems 36–40.   
Given that alcohol craving is a dynamic state of desire to drink, a person’s capacity 
for impulse regulation is expected to moderate alcohol approach behaviour in response to 
craving. Patients with high trait rash impulsiveness would then be expected to be at greater 
risk of lapse during treatment in response to an episode of craving. No research has been 
identified which has examined this proposed relationship.  
 There is also a potential direct relationship between impulsivity and craving, with 
several recent cross-sectional and experimental studies finding patients with greater 
impulsivity experience stronger cravings. Laboratory studies have found higher impulsivity 
to be predictive of greater cue-induced cravings among smokers 41, social drinkers, and 
alcohol dependent patients 42,43. Across three studies, Kambouropoulos and Staiger 12–14 
found reward drive consistently predicted cue-elicited craving in social drinkers, while one 
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study showed that rash impulsiveness only predicted cue-elicited positive affect 14. By 
contrast, Evren et al.11 found high rash impulsiveness was predictive of greater alcohol 
craving in alcohol dependent patients. Pre-treatment craving, but not rash impulsiveness, was 
predictive of relapse at 12-months 11. This prompted authors to suggest that craving may 
mediate the effect of rash impulsiveness on relapse.  
This study aims to explore the relationships between rash impulsiveness, alcohol 
craving, and lapse events during abstinence-oriented Cognitive-Behaviour Therapy (CBT) for 
patients with established AUD. We predicted that rash impulsiveness would be significantly 
positively predictive of craving (H1). Both craving and impulsivity were expected to be 
associated with greater likelihood of lapse during treatment (H2 and H3). Craving was 
expected to mediate the effects of rash impulsiveness on lapse (H4). Finally, higher rash 
impulsiveness was predicted to enhance the risk of lapse in response to craving (moderation, 
H5).  
Method 
Participants and Procedure 
Subjects were consecutive patients (n = 304) attending a university metropolitan 
hospital outpatient drug and alcohol service for treatment of AUD. Sample characteristics are 
presented in Table 1. Referral to the alcohol and drug service was typically made by inpatient 
hospital referral or a community based General Practitioner. Intake interview was conducted 
by a nurse or social worker, who determined eligibility for the AUD treatment program and 
administered pre-treatment assessments. Patients were reviewed by an Addiction Medicine 
Physician. Pre-treatment assessments included assessment of AUD, dependence severity, 
baseline craving frequency, and rash impulsiveness. Inclusion in treatment required that 
patients meet DSM-IV criteria for alcohol dependence and commit to a goal of 12-weeks of 
abstinence. This clinically indicated treatment goal reflected the severity of the AUD sample 
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2. Patients were excluded from this study if they had a co-morbid substance dependence (with 
the exception of nicotine) or if they were taking Disulfiram or a prescribed opioid for opiate 
dependence. Patients were scheduled to begin treatment within 7-days following intake. The 
program included eight, one-hour sessions of CBT conducted over 12-weeks. Treatment was 
administered one-on-one by clinical psychologists with Masters or Doctoral level 
qualifications. Psychologists recorded drinking behaviour, craving, and adjunct 
pharmacotherapy (naltrexone, acamprosate, or both) at each treatment session. Human 
research ethics approval was obtained (HREC/12/QPAH/022, HREC/14/QPAH/664).  
Measures 
The Severity of Alcohol Dependence Questionnaire (SADQ)  
The SADQ contains 20 self-report items on a 4-point scale from 0 (almost never) to 3 
(nearly always), assessing physical withdrawal, affective withdrawal, drinking to relieve 
withdrawal symptoms, alcohol consumption, and rapidity of reinstatement of alcohol 
dependence 44. For AUD patients scores ≤ 15 are indicative of mild dependence, scores 
between 16 and 30 indicate moderate dependence, and scores ≥ 31 suggest severe 
dependence. The SADQ has strong psychometric properties with good test-retest reliability 
and concurrent validity 44. Internal consistency of the SADQ within this study was good 
(Cronbach’s α = 0.92, 95% CI = 0.91-0.93). The SADQ was included within the pre-
treatment assessment battery at patient intake.  
The Alcohol Craving Experience Questionnaire – Frequency (ACE-F) 
The ACE-F is a self-report measure assessing the frequency of desire related 
cognitions over the previous week. The ACE-F comprises 11-items on an 11-point visual 
analogue scale, anchored 0 (not at all) to 10 (constantly/extremely). The ACE-F has good 
construct validity, predictive validity, concurrent validity, discriminant validity, internal 
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reliability, and test-retest reliability 45–47. Internal consistency of the ACE-F within the current 
study was excellent (Cronbach’s α = 0.95, 95% CI = 0.94-0.95). The ACE-F was included 
within the pre-treatment assessment battery at patient intake and re-administered at each 
treatment session.  
Dickman’s Impulsivity Inventory - Dysfunctional Impulsivity Scale (DIS) 
Dickman’s Impulsivity Inventory is a self-report questionnaire comprising two scales: 
Functional Impulsivity and Dysfunctional Impulsivity. The Dysfunctional Impulsivity scale 
(DIS) assesses the tendency to act with little forethought where this leads to negative 
consequences 48, and is a valid measure of rash impulsiveness 24,49. The DIS comprises 12-
items with dichotomous (True/False) response options. The DIS has demonstrated good 
internal reliability, construct validity, and excellent concurrent validity when compared with 
other established impulsivity scales 48,50. Good internal consistency was identified within this 
sample (Cronbach’s α = 0.84, 95% CI = 0.82 - 0.86). The DIS was included within the pre-
treatment assessment battery at patient intake. 
Drinking Behaviour  
Guided by the Time-Line Follow-Back procedure 51 experienced clinical 
psychologists asked patients to recall any drinking occasions which occurred between each 
session, report the type of alcohol consumed, and estimate volume of consumption. Any 
alcohol consumption between treatment sessions was coded as a lapse.   
Statistical Analysis 
As craving is proposed to mediate rash impulsiveness in the prediction of lapse, there 
are two primary outcomes within the study, ACE-F score (craving) and lapse status (abstinent 
or lapsed). For each outcome, two effects were modelled: the main effects on the outcome 
(intercept) and effects on the trajectory of the outcome as sessions progress (slope). 
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Longitudinal linear mixed models (LMM) enabled both effects to be modelled while 
controlling for intra and inter-personal differences. LMMs are particularly well suited to 
psychotherapy research as they allow for incomplete and unbalanced data 52,53. The number 
of sessions each patient attended was included in the analyses to model potential effects on 
the outcome dependent on the missing data process 53,54.  
All data analysis was conducted in R version 3.3.3. LMMs were constructed by R 
package ‘lme4’ 55 using Maximum Likelihood estimation. All models included random 
intercepts. Random slopes were assessed and retained if found to improve model fit and 
affect parameter estimates. Statistical significance at p < 0.05 was determined by Wald 
estimated 95% CIs excluding zero.  Session number was re-coded by subtracting one to set 
the lower limit to zero (e.g. Session 1 = 0, session 2 = 1).  Session number and potential 
covariates were entered in the first step of each model, as well as ‘session number × 
covariate’ interactions to detect covariate effects on the trajectory of the outcome.  Only 
statistically significant covariates were retained. When the interaction was significant, but not 
the main effect, both terms were retained. Covariates included: age, gender, dependence 
severity (SADQ, total number of sessions attended, days between sessions, and adjunctive 
pharmacotherapy 9,56,57. As this sample includes patients enrolled in a personalised treatment 
condition as part of a randomised controlled trial (RCT; n = 137) 8, this was included as a 
covariate to control for potential response differences between groups 58.  
Individual ordinary least squares plots and normality probability plots were inspected 
to assess violations of linearity and normality assumptions. To identify potential bias arising 
from violation of statistical assumptions, sensitivity analyses were conducted by comparing 
all LMMs based on Maximum Likelihood estimation to Design Adaptive Scale Tau 
estimation, a robust LMM variant 59,60. Robust LMMs were constructed by R package 
‘robustlmm’ 60. When the estimates provided by both models were ostensibly the same, the 
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original model is reported. When discrepancy between the models was observed the robust 
model is reported. 
Hypothesis Testing  
H1) Rash impulsiveness will be significantly positively predictive of craving. LMMs 
were used to assess the relationship between pre-treatment impulsivity score and the 
trajectory of craving over treatment.  
H2 & H3) Higher craving and rash impulsiveness will predict greater likelihood of 
lapse. Separate logistic LMMs were used to assess the prognostic value of pre-treatment 
ACE-F and DIS in the prediction of lapse-likelihood. Prediction of the slope of lapse-
likelihood was also assessed by including ‘predictor’ x ‘session number’ interaction terms. 
Session by session ACE-F scores were included in a separate model to examine the effect of 
craving trajectory on the slope of lapse-likelihood over treatment.  
H4) Craving will mediate the effect of rash impulsiveness in prediction of lapse. 
Consistent with the joint significance procedure 61 evidence for mediation was determined by 
a significant association between predictor and mediator (Path a), and a significant 
relationship between the mediator and outcome (Path b). Indirect effects and 95% confidence 
intervals (CI) were estimated by the product-of-coefficients method using R package 
‘Rmediation’ 62,63. As the lapse outcome variable was dichotomous, path a and b coefficients 
were standardized to correct for differences in mediator/outcome distributions and residual 
variance 64. 
H5) Higher rash impulsiveness will increase the risk of lapse in response to craving.  
Interaction between craving and impulsivity in the prediction of lapse was assessed by adding 
‘impulsivity × craving and ‘impulsivity × craving × Session Number’ terms to a logistic 
LMM model. 
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Results 
Descriptive statistics and Missing Data 
The mean number of sessions (range 1-8) attended was 5.22 (SD = 2.20). Eighty-
seven patients (29%) completed all 8 sessions or 12-weeks of treatment. Among those who 
completed treatment, 37 (43%) completed without lapse. Patients who completed treatment 
were significantly older (M = 46.01, SD = 10.45) than non-completers (M = 43.24, SD = 
10.64; t(468) = -2.80, p =0.005). No other significant differences between treatment 
‘completers’ and ‘non-completers’ were observed on any demographic variables or pre-
treatment assessments. 
Table 1. Descriptive Statistics of the Sample (N = 304) 
 Mean SD Range 
Age (years) 45.05 10.69 20 - 76 
Alcohol Use Disorder Identification Test 27.73 8.90 0 - 40 
Severity of Alcohol Dependence 22.79 12.93 0 - 58 
Rash Impulsiveness 4.51 3.43 0 - 12 
Pre-treatment Alcohol Craving Experience 45.10 29.13 0 - 110 
    
 n %  
    
Gender    
  Female 104 34.21  
  Male 200 65.79  
    
Pharmacotherapy    
  Yes 122 40.13  
  No 182 59.87  
    
Active Treatment Trial    
  Yes 137 45.07  
  No 167 54.93  
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H1) Rash impulsiveness will be significantly positively predictive of craving.  
LMMs were used to examine the relationship between the pre-treatment rash impulsiveness 
and craving over treatment. Covariates RCT enrolment, treatment completion, and adjunctive 
pharmacotherapy had no significant effect on the craving intercept or slope and were not 
retained. Age and gender had no significant effects on the slope of craving over treatment, so 
their respective session number interaction terms were excluded. Independent of covariates, 
craving was found to reduce over treatment in the order of 5.92 points per session (95% CI = 
-8.78, -3.05; = 0.20 SDs). Each unit increase in baseline impulsivity score was predictive of a 
0.95 (95% CI = 0.40, 1.50) higher craving score. Patients scoring +1 SD above the mean on 
rash impulsiveness reported +3.26 points higher craving (= 0.11 SDs). No time-dependent 
effect of impulsivity on craving was observed (Table 2, Model 1; figure 1) so this interaction 
term was not retained (Table 2, Model 2). Sensitivity analyses utilising robust methods 
yielded consistent results, indicating that any violations to statistical assumptions did not 
meaningfully affect the present findings.  
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Figure 1. Trajectory of predicted craving over treatment by high (+1 SD) and low (-1 SD) 
pre-treatment rash impulsiveness scores. The shaded areas are standard errors. Higher 
impulsivity is predictive of higher craving independent of time (Table 2, Model 1).  
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Table 2. Summary of linear mixed-effects regression models predicting alcohol craving 
during treatment (N = 304). 
Parameter Model 1 Model 2 
Fixed Effects b (SE) 95% CI b (SE) 95% CI 
 Intercept 40.75 (6.78) 27.47, 54.03 41.15 (6.74) 27.94, 54.36 
 Session Number -5.80 (1.48) -8.70, -2.90 -5.96 (1.46) -8.81, -3.10 
 Age -0.21 (0.11) -0.42, 0.002 -0.21 (0.11) -0.42, 0.002 
 Severity of Dependence 0.57 (0.10) 0.37, 0.77 0.58 (0.10) 0.38, 0.77 
 Gender (Male) -7.90 (2.30) -12.41, -3.39 -7.93 (2.30) -12.43, -3.42 
 Sessions Attended -1.26 (0.58) -2.4, -0.12 -1.27 (0.58) -2.4, -0.13 
 Days Between Sessions -0.20 (0.11) -0.43, 0.02 -0.20 (0.11) -0.43, 0.02 
 Session Number × Severity of Dependence -0.04 (0.02) -0.08, 0.001 -0.04 (0.02) -0.08, 0.001 
 Session Number × Sessions Attended 0.40 (0.19) 0.02, 0.78 0.40 (0.19) 0.03, 0.78 
 Session Number × Days Between Sessions 0.08 (0.03) 0.02, 0.13 0.08 (0.03) 0.02, 0.13 
 Rash Impulsiveness 1.00 (0.38) 0.26, 1.74 0.89 (0.33) 0.25, 1.54 
 Session Number × Rash Impulsiveness -0.04 (0.07) -0.18, 0.10    
Random Effects σ2  σ2  
 Patient (Intercept) 283.15  282.93  
 Residual 180.99   181.10  
 
Note: Boldface indicates p < 0.05 as 95% confidence intervals do not include zero. All parameters are 
unstandardized. 
 
H2 & H3) Higher craving and impulsivity will predict greater likelihood of lapse. 
Logistic LMMs were used in the prediction of lapse-likelihood (Table 3). Covariates 
age, gender, severity of dependence, combined pharmacotherapy, number of sessions 
attended and RCT enrolment had no significant effect on the intercept or slope of log-
likelihood of lapse and were excluded. Within the baseline model each progressive session 
was associated with 14% increase in the probability of lapse.  
Pre-treatment impulsivity was not predictive of lapse at session 1 but was predictive 
of greater lapse-likelihood as sessions progressed (Table 3., Model 3). When craving was 
added to the model impulsivity became non-significant, while craving was significant in the 
prediction of the slope of lapse-likelihood (Table 3., Model 5). Higher craving over treatment 
was associated with greater likelihood of lapse as treatment progressed (Table 3., Model 4; 
Figure 2).  
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Figure 2. Probability of lapse over treatment by craving score. The shaded areas are 95% 
confidence intervals. Higher craving over treatment is associated with greater probability of 
lapse (Table 2, Model 4).   
H4) Craving will mediate the effect of impulsivity in prediction of lapse.  
As pre-treatment impulsivity was significantly associated with craving (path a) and 
craving was predictive of lapse-likelihood during treatment (path b), there is evidence for 
mediation under the joint-significance approach. Product-of-coefficients estimates of the 
indirect effect of impulsivity score on lapse-likelihood was significant (µ = 0.11, SE = 0.05, 




Figure 3. Mediation model of pre-treatment rash impulsiveness and craving in the prediction 
of lapse risk during treatment. 
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* 95% confidence intervals non-inclusive of zero.  
 
H5) Higher rash impulsiveness will increase the risk of lapse in response to craving.   
Interaction terms ‘craving × rash impulsiveness’ and ‘craving × rash impulsiveness × 
session number’ were included in a logistic LMM predicting lapse-likelihood (Table 3, 
Model 6). Neither interaction term was significant (Table 3., Model 6), yielding no support 
for moderation of craving by impulsivity in the prediction of the intercept or slope of lapse-
likelihood over treatment. 
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Table 3. Summary of mixed-effects logistic regression models predicting lapse (N = 304). 
Parameter Model 3 Model 4 Model 5 Model 6 
Fixed Effect b (SE) 95% CI b (SE) 95% CI b (SE) 95% CI b (SE) 95% CI 
 Intercept -2.53 (0.39) -3.29, -1.77 -3.52 (0.51) -4.52, -2.52 -3.52 (0.58) -4.66, -2.38 -3.43 (0.68) -4.77, -2.09 
 Session Number -0.001 (0.07) -0.14, 0.14 0.02 (0.09) -0.16, 0.19 -0.05 (0.11) -0.26, 0.17 -0.06 (0.14) -0.33, 0.21 
 Gender (Male) -0.67 (0.3) -1.26, -0.08 -0.45 (0.35) -1.15, 0.24 -0.47 (0.36) -1.16, 0.23 -0.46 (0.36) -1.16, 0.24 
 Days Between Sessions 0.04 (0.01) 0.02, 0.06 0.05 (0.01) 0.02, 0.07 0.05 (0.01) 0.02, 0.07 0.05 (0.01) 0.02, 0.07 
 Rash Impulsiveness 0.02 (0.05) -0.09, 0.12   -0.01 (0.07) -0.14, 0.13 -0.03 (0.11) -0.25, 0.19 
 Session Number × Rash Impulsiveness 0.03 (0.01) 0.003, 0.05   0.02 (0.02) -0.02, 0.05 0.02 (0.03) -0.03, 0.07 
 Craving   0.01 (0.01) -0.001, 0.03 0.02 (0.01) -0.001, 0.031 0.01 (0.01) -0.02, 0.04 
 Session Number × Craving   0.01 (0.003) 0.01, 0.02 0.01 (0.003) 0.01, 0.01 0.01 (0.004) 0.001, 0.02 
 Craving × Rash Impulsiveness       0.001 (0.002) -0.004, 0.01 
 Session Number × Craving × Rash Impulsiveness       0.001 (0.001) -0.001, 0.001 
Random Effects σ2  σ2  σ2  σ2  
 Patient (Intercept) 3.59   4.23   4.31   4.33   
 
Note: Boldface indicates p < 0.05 as 95% confidence intervals do not include zero. All parameters are unstandardised on a log-likelihood scale. 
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Discussion 
This is the first study to investigate the relationship between rash impulsiveness and 
craving in the prediction of response to treatment for alcohol dependence. Higher rash 
impulsiveness was predictive of more frequent craving over treatment, which was associated 
with greater risk of lapse. The indirect effect of impulsivity via its effect on craving was 
found to be significant, supporting the hypothesised mediation. The moderation hypothesis 
that higher rash impulsiveness would increase risk of lapse in response to craving frequency, 
was not supported.  
This study replicated previous research finding a positive association between craving 
and rash impulsiveness among AUD patients 11,65. Consistent with previous studies, higher 
craving 15,20,66 and impulsivity 11,34 were independently predictive of poorer treatment 
outcomes. Craving was found to diminish the unique effect attributed to rash impulsiveness 
when included within the same model. This supports the present findings that craving 
mediates rash impulsiveness as the final path to lapse. One explanation for this mediational 
process is that patients high in rash impulsiveness have an impaired cognitive ability to 
inhibit craving cognitions 67,68. A cognitive model of desire, Elaborated Intrusion (EI) 
Theory, provides one theoretical framework by which this process may occur 16,69. EI theory 
suggests that intrusive desire-related cognitions demand elaboration upon entering conscious 
awareness. Elaboration includes planning and appraisal of substance related behaviours and is 
self-reinforcing as cognitions oriented toward craving relief provide fleeting moments of 
pleasure. An individual’s capacity to intervene early within this cycle, via distraction or 
reorientation is considered crucial to restricting the intensity of the craving experience. As 
patients with high rash impulsiveness are more likely to have difficulties on tasks requiring 
cognitive inhibition 70, they may be more vulnerable to elaboration of craving cognitions, 
resulting in more frequent and intense bouts of craving.  
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The hypothesis that patients higher in rash impulsiveness would be at greater risk of 
lapse in response to craving was not supported, suggesting inhibition of alcohol approach 
behaviours during craving is a significant challenge for patients regardless of trait 
impulsivity.  
While craving frequency was found to diminish over the treatment period, the relative 
risk of lapse in response to craving increased as sessions progressed (Figure 2). This pattern 
may be due to persistent demands on craving inhibition, involving executive processes such 
as appraisal and reappraisal of proximal and distal expectations of alcohol consumption 16,71. 
Reappraisal may lead to fluctuations in motivation for abstinence and drinking refusal self-
efficacy 31. For example, patients whose experience of craving causes more distress than 
anticipated may develop stronger positive expectations of the effects of alcohol on tension 
reduction, motivating use via negative reinforcement contingencies which undermine self-
efficacy. As drinking refusal self-efficacy has been found to mediate the association between 
rash impulsiveness and hazardous drinking among AUD patients 31, future research should 
consider whether craving mediates rash impulsiveness in the prediction of drinking refusal 
self-efficacy. 
An important feature of this study was its control of common covariates. However, as 
covariate hypotheses were not developed a-priori, effects identified should be interpreted 
modestly and within the context of past research. Younger patients were initially found to be 
subject to more frequent cravings, supporting findings from an actively drinking alcohol 
dependent sample 57. However, this effect become non-significant when impulsivity was 
included in the analysis. It may be that younger patients have higher levels of impulsiveness 
which predisposes them to craving 72,73. Future research may examine whether impulsivity 
mediates the effect of age on craving. Finally, women reported significantly more frequent 
craving than men. Few studies have considered gender with respect to alcohol craving, 
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though females have been demonstrated to experience stronger cravings for cocaine 74 and 
food 75. Affective, endocrine, and neurobiological differences between males and females 
have been recognised as potential mechanisms contributing to differences in craving 76–78. 
Future research may explore in detail gender differences in alcohol craving, and whether 
craving mediates the relationship between impulsivity and lapse similarly for women and 
men.  
This study has some limitations. As rash impulsiveness was only measured at time 
one, the direction of effect between impulsivity and craving could not be tested statistically. 
The direction of mediation was inferred from theory proposing impulsivity is a relatively 
stable trait 23 and experimental research demonstrating that impulsivity predicts strength of 
craving 41–43. However, without frequent assessment of both impulsivity and craving this 
study cannot confirm directionality. Another limitation is the craving measure used reflects 
past-week craving frequency, which does not capture phasic cycles in craving strength. Rash 
impulsiveness may be differentially related to strength and frequency of craving. For 
example, impulsive patients may have more difficulty resisting episodes of strong craving 
than persistent low levels of craving. Measures of rash impulsiveness also correlate with 
reward drive 22, which has been shown to predict craving (Kambouropoulos & Staiger, 2001; 
2004; 2009). Controlling for patient reward drive in future studies would clarify the unique 
role of rash impulsiveness in craving. Reliance upon self-report is another limitation, 
restricting insight into the nonconscious features of impulsivity and craving discussed within 
the proposed theoretical processes. Assessment of drinking behaviours was also reliant upon 
self-report introducing potential memory bias and deception. Additional biological markers 
of alcohol use may be beneficial to corroborate self-report, though voluntary enrolment in 
treatment, and breath estimated BAL at the beginning of each session was expected to 
minimise deception 79.  
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Frequent assessment of craving, alcohol expectancies, motivation, and drinking-
refusal self-efficacy is required to better understand the temporal relationships between these 
constructs in relation to treatment response 31,80. These findings support frequent assessment 
of craving in patients with AUD to inform lapse risk and treatment approach 81. Future 
research may also consider including craving as a marker of treatment response within 
adaptive algorithms for personalised interventions 7,81,82. Patients with persistent craving are 
likely to benefit from greater emphasis on coping strategies, craving psychoeducation, or 
adjunctive pharmacotherapy 83–85. 
 
Acknowledgements: We would like to acknowledge Annie McPherson, Jane Tucker, Karen 
Dillman, and Daniel Park at the Alcohol and Drug Assessment Unit for their assistance in this 
research.  
Funding: MJG is supported by a National Health and Medical Research Council (NHMRC) 
Early Career Fellowship (1036365). JPC is supported by a NHMRC Career Development 
Fellowship (1031909). Funders had no input into the design, analysis or interpretation of 
results. 
Declarations of interest: none 
Contributors: All authors were involved in designing the study. JMC conducted the 
statistical analyses and led development of the first draft. All authors contributed to drafting 





Page 21 of 29 
 
References 
1. Cunningham, J. a. & McCambridge, J. Is alcohol dependence best viewed as a chronic 
relapsing disorder? Addiction 107, 6–12 (2012). 
2. Connor, J. P., Haber, P. S. & Hall, W. D. Alcohol use disorders. Lancet 387, 988–998 
(2016). 
3. UKATT Research Team. Effectiveness of treatment for alcohol problems: findings of 
the randomised UK alcohol treatment trial (UKATT). Bmj 331, 541 (2005). 
4. Project MATCH Research Group. Matching patients with alcohol disorders to 
treatments: Clinical implications from Project MATCH. J. Ment. Heal. (1998). 
5. Longabaugh, R. & Magill, M. Recent Advances in Behavioral Addiction Treatments: 
Focusing on Mechanisms of Change. Curr. Psychiatry Rep. 13, 382–389 (2011). 
6. Norcross, J. C. & Wampold, B. E. What works for whom: Tailoring psychotherapy to 
the person. J. Clin. Psychol. 67, 127–132 (2011). 
7. Kranzler, H. R. & McKay, J. R. Personalized treatment of alcohol dependence. Curr. 
Psychiatry Rep. 14, 486–493 (2012). 
8. Coates, J. M., Gullo, M. J., Feeney, G. F. X., Young, R. M. & Connor, J. P. A 
Randomized Trial of Personalized Cognitive-Behavior Therapy for Alcohol Use 
Disorder in a Public Health Clinic. Front. Psychiatry 9, 1–12 (2018). 
9. Adamson, S. J., Sellman, J. D. & Frampton, C. M. a. Patient predictors of alcohol 
treatment outcome: A systematic review. J. Subst. Abuse Treat. 36, 75–86 (2009). 
10. Magill, M. & Longabaugh, R. Efficacy combined with specified ingredients: A new 
direction for empirically supported addiction treatment. Addiction 108, 874–881 
(2013). 
11. Evren, C., Durkaya, M., Evren, B., Dalbudak, E. & Cetin, R. Relationship of relapse 
with impulsivity, novelty seeking and craving in male alcohol-dependent inpatients. 
Drug Alcohol Rev. 31, 81–90 (2012). 
Page 22 of 29 
 
12. Kambouropoulos, N. & Staiger, P. K. ‘Cue reward salience’ predicts craving in 
response to alcohol cues. Pers. Individ. Dif. 46, 78–82 (2009). 
13. Kambouropoulos, N. & Staiger, P. K. The influence of sensitivity to reward on 
reactivity to alcohol-related cues. Addiction 96, 1175–1185 (2001). 
14. Kambouropoulos, N. & Staiger, P. K. Reactivity to alcohol-related cues: Relationship 
among cue type, motivational processes, and personality. Psychol. Addict. Behav. 18, 
275–283 (2004). 
15. Bottlender, M. & Soyka, M. Impact of craving on alcohol relapse during, and 12 
months following, outpatient treatment. Alcohol Alcohol. 39, 357–361 (2004). 
16. Kavanagh, D. J., Andrade, J. & May, J. Imaginary relish and exquisite torture: The 
elaborated intrusion theory of desire. Psychol. Rev. 112, 446–467 (2005). 
17. Sayette, M. A. et al. The measurement of drug craving. Addiction 95, 189–210 (2000). 
18. Monti, P. M., Rohsenow, D. J. & Hutchison, K. E. Toward bridging the gap between 
biological, psychobiological and psychosocial models of alcohol craving. Addiction 95 
Suppl 2, 229–236 (2000). 
19. Hasin, D. S. et al. DSM-5 criteria for substance use disorders: Recommendations and 
rationale. Am. J. Psychiatry 170, 834–851 (2013). 
20. Flannery, B. A., Poole, S. A., Gallop, R. J. & Volpicelli, J. R. Alcohol craving predicts 
drinking during treatment: an analysis of three assessment instruments. J. Stud. 
Alcohol 64, 120–126 (2003). 
21. Pavlick, M., Hoffmann, E. & Rosenberg, H. A nationwide survey of American alcohol 
and drug craving assessment and treatment practices. Addict. Res. Theory 17, 591–600 
(2009). 
22. Gullo, M. J., Loxton, N. J. & Dawe, S. Impulsivity: four ways five factors are not basic 
to addiction. Addict. Behav. 39, 1547–56 (2014). 
Page 23 of 29 
 
23. Dawe, S., Gullo, M. J. & Loxton, N. J. Reward drive and rash impulsiveness as 
dimensions of impulsivity: Implications for substance misuse. Addict. Behav. 29, 
1389–1405 (2004). 
24. Boog, M., Goudriaan, A. E., Van De Wetering, B. J. M., Deuss, H. & Franken, I. H. A. 
The concepts of rash impulsiveness and reward sensitivity in substance use disorders. 
Eur. Addict. Res. 19, 261–268 (2013). 
25. Stautz, K., Dinc, L. & Cooper, A. J. Combining Trait Models of Impulsivity to 
Improve Explanation of Substance Use Behaviour. Eur. J. Pers. 31, 118–132 (2017). 
26. Whiteside, S. P. & Lynam, D. R. The Five Factor Model and impulsivity: using a 
structural model of personality to understand impulsivity. Pers. Individ. Dif. 30, 669–
689 (2001). 
27. Zuckerman, M., Kuhlman, D. M., Joireman, J., Teta, P. & Kraft, M. A Comparison of 
Three Structural Models for Personality: The Big Three, the Big Five, and the 
Alternative Five. J. Pers. Soc. Psychol. 65, 757–768 (1993). 
28. Patton, J. H., Stanford, M. S. & Barratt, E. S. Factor structure of the barratt 
impulsiveness scale. J. Clin. Psychol. 51, 768–774 (1995). 
29. Gullo, M. J. et al. A laboratory model of impulsivity and alcohol use in late 
adolescence. Behav. Res. Ther. 97, 52–63 (2017). 
30. George, S. M., Connor, J. P., Gullo, M. J. & Young, R. M. A Prospective Study of 
Personality Features Predictive of Early Adolescent Alcohol Misuse. Pers. Individ. 
Dif. 49, 204–209 (2010). 
31. Gullo, M. J., Dawe, S., Kambouropoulos, N., Staiger, P. K. & Jackson, C. J. Alcohol 
expectancies and drinking refusal self-efficacy mediate the association of impulsivity 
with alcohol misuse. Alcohol. Clin. Exp. Res. 34, 1386–99 (2010). 
32. Urošević, S. et al. Effects of reward sensitivity and regional brain volumes on 
Page 24 of 29 
 
substance use initiation in adolescence. Soc. Cogn. Affect. Neurosci. 10, 106–113 
(2015). 
33. Sher, K. J., Bartholow, B. D. & Wood, M. D. Personality and substance use disorders: 
A prospective study. J. Consult. Clin. Psychol. 68, 818–829 (2000). 
34. Charney, D. a., Zikos, E. & Gill, K. J. Early recovery from alcohol dependence: 
Factors that promote or impede abstinence. J. Subst. Abuse Treat. 38, 42–50 (2010). 
35. Müller, S. E., Weijers, H. G., Böning, J. & Wiesbeck, G. a. Personality traits predict 
treatment outcome in alcohol-dependent patients. Neuropsychobiology 57, 159–164 
(2008). 
36. Goldstein, R. Z. & Volkow, N. D. Drug addiction and its underlying neurobiological 
basis: Neuroimaging evidence for the involvement of the frontal cortex. Am. J. 
Psychiatry 159, 1642–1652 (2002). 
37. Jentsch, J. D. & Taylor, J. R. Impulsivity resulting from frontostriatal dysfunction in 
drug abuse: Implications for the control of behavior by reward-related stimuli. 
Psychopharmacology (Berl). 146, 373–390 (1999). 
38. Koob, G. F. & Volkow, N. D. Neurocircuitry of addiction. Neuropsychopharmacology 
35, 217–238 (2010). 
39. Swick, D., Ashley, V. & Turken, U. Are the neural correlates of stopping and not 
going identical? Quantitative meta-analysis of two response inhibition tasks. 
Neuroimage 56, 1655–1665 (2011). 
40. Whelan, R. et al. Adolescent impulsivity phenotypes characterized by distinct brain 
networks. Nat. Neurosci. 15, 920–927 (2012). 
41. Doran, N., Spring, B. & McChargue, D. Effect of impulsivity on craving and 
behavioral reactivity to smoking cues. Psychopharmacology (Berl). 194, 279–288 
(2007). 
Page 25 of 29 
 
42. Yarmush, D. E., Manchery, L., Luehring-Jones, P. & Erblich, J. Gender and 
Impulsivity: Effects on Cue-Induced Alcohol Craving. Alcohol. Clin. Exp. Res. 40, 
1052–1057 (2016). 
43. Papachristou, H., Nederkoorn, C., Havermans, R., Van Der Horst, M. & Jansen, A. 
Can’t stop the craving: The effect of impulsivity on cue-elicited craving for alcohol in 
heavy and light social drinkers. Psychopharmacology (Berl). 219, 511–518 (2012). 
44. Stockwell, T., Murphy, D. & Hodgson, R. The severity of alcohol dependence 
questionnaire: its use, reliability and validity. Br. J. Addict. 78, 145–155 (1983). 
45. Statham, D. J. et al. Measuring alcohol craving: Development of the Alcohol Craving 
Experience questionnaire. Addiction 106, 1230–1238 (2011). 
46. Coates, J. M. et al. The Mini Alcohol Craving Experience Questionnaire: 
Development and Clinical Application. Alcohol. Clin. Exp. Res. 41, 156–164 (2017). 
47. May, J. et al. The Craving Experience Questionnaire: A brief, theory-based measure of 
consummatory desire and craving. Addiction 109, 728–35 (2014). 
48. Dickman, S. J. Functional and dysfunctional impulsivity: personality and cognitive 
correlates. J. Pers. Soc. Psychol. 58, 95–102 (1990). 
49. Franken, I. H. A. & Muris, P. Gray’s impulsivity dimension: A distinction between 
Reward Sensitivity versus Rash impulsiveness. Pers. Individ. Dif. 40, 1337–1347 
(2006). 
50. Claes, L., Vertommen, H. & Braspenning, N. Psychometric properties of the Dickman 
Impulsivity Inventory. Pers. Individ. Dif. 29, 27–35 (2000). 
51. Sobell, L. C. & Sobell, M. B. Timeline Follow-Back. in Measuring Alcohol 
Consumption (eds. Litten, R. Z. & Allen, J.) 41–72 (Humana Press, 1992). 
doi:10.1007/978-1-4612-0357-5_3 
52. Tasca, G. a & Gallop, R. Multilevel modeling of longitudinal data for psychotherapy 
Page 26 of 29 
 
researchers: I. The basics. Psychother. Res. 19, 429–437 (2009). 
53. Gallop, R. & Tasca, G. a. Multilevel modeling of longitudinal data for psychotherapy 
researchers: II. The complexities. Psychother. Res. 19, 438–452 (2009). 
54. Hedeker, D. & Gibbons, R. D. Application of random-effects pattern-mixture models 
for missing data in longitudinal studies. Psychol. Methods 2, 64–78 (1997). 
55. Bates, D., Mächler, M., Bolker, B. M. & Walker, S. C. Fitting linear mixed-effects 
models using lme4. J. Stat. Softw. 67, 1–48 (2015). 
56. Jonas, D. E. et al. Pharmacotherapy for Adults With Alcohol Use Disorders in 
Outpatient Settings. Jama 311, 1889 (2014). 
57. Chakravorty, S. et al. Covariates of craving in actively drinking alcoholics. Am. J. 
Addict. 19, 450–457 (2010). 
58. Witkiewitz, K. et al. Temporal Stability of Heavy Drinking Days and Drinking 
Reductions Among Heavy Drinkers in the COMBINE Study. Alcohol. Clin. Exp. Res. 
41, 1054–1062 (2017). 
59. Field, A. P. & Wilcox, R. R. Robust statistical methods: A primer for clinical 
psychology and experimental psychopathology researchers. Behav. Res. Ther. 98, 19–
38 (2016). 
60. Koller, M. robustlmm : An R Package for Robust Estimation of Linear Mixed-Effects 
Models. J. Stat. Softw. 75, (2016). 
61. MacKinnon, D. P., Lockwood, C. M., Hoffman, J. M., West, S. G. & Sheets, V. A 
comparison of methods to test mediation and other intervening variable effects. 
Psychol. Methods 7, 83–104 (2002). 
62. MacKinnon, D. P., Fritz, M. S., Williams, J. & Lockwood, C. M. Distribution of the 
product confidence limits for the indirect effect: Program PRODCLIN. Behav. Res. 
Methods 39, 384–389 (2007). 
Page 27 of 29 
 
63. Tofighi, D. & MacKinnon, D. P. RMediation: An R package for mediation analysis 
confidence intervals. Behav. Res. Methods 43, 692–700 (2011). 
64. Mackinnon, D. P. & Dwyer, J. H. Estimating Mediated Effects in Prevention Studies. 
Eval. Rev. 17, 144–158 (1993). 
65. Joos, L. et al. The relationship between impulsivity and craving in alcohol dependent 
patients. Psychopharmacology (Berl). 226, 273–283 (2013). 
66. Law, B. et al. Craving Mediates Stress in Predicting Lapse During Alcohol 
Dependence Treatment. Alcohol. Clin. Exp. Res. 40, 1058–1064 (2016). 
67. Verdejo-García, A. et al. Effect of craving induction on inhibitory control in opiate 
dependence. Psychopharmacology (Berl). 219, 519–526 (2012). 
68. Naqvi, N. H. et al. Cognitive Regulation of Craving in Alcohol-Dependent and Social 
Drinkers. Alcohol. Clin. Exp. Res. 39, 343–349 (2015). 
69. May, J., Kavanagh, D. J. & Andrade, J. The Elaborated Intrusion Theory of desire: A 
10-year retrospective and implications for addiction treatments. Addict. Behav. 44, 29–
34 (2015). 
70. Bari, A. & Robbins, T. W. Inhibition and impulsivity: Behavioral and neural basis of 
response control. Prog. Neurobiol. 108, 44–79 (2013). 
71. Bandura, A. A sociocognitive analysis of substance abuse: An agentic perspective. 
Psychol. Sci. 10, 214–217 (1999). 
72. Eysenck, S. B. G., Pearson, P. R., Easting, G. & Allsopp, J. F. Age norms for 
impulsiveness, venturesomeness and empathy in adults. Pers. Individ. Dif. 6, 613–619 
(1985). 
73. Quinn, P. D. & Harden, K. P. Differential changes in impulsivity and sensation 
seeking and the escalation of substance use from adolescence to early adulthood. Dev. 
Psychopathol. 25, 223–239 (2013). 
Page 28 of 29 
 
74. Elman, I., Karlsgodt, K. H. & Gastfriend, D. R. Gender differences in cocaine craving 
among non-treatment-seeking individuals with cocaine dependence. Am. J. Drug 
Alcohol Abuse 27, 193–202 (2001). 
75. Cepeda-Benito, A., Fernandez, M. C. & Moreno, S. Relationship of gender and eating 
disorder symptoms to reported cravings for food: Construct validation of state and trait 
craving questionnaires in Spanish. Appetite 40, 47–54 (2003). 
76. Kraus, T. et al. Leptin is associated with craving in females with alcoholism. Addict. 
Biol. 9, 213–219 (2004). 
77. Zilberman, M. L., Tavares, H. & El-Guebaly, N. Relationship between craving and 
personality in treatment-seeking women with substance-related disorders. BMC 
Psychiatry 3, 1 (2003). 
78. Kiefer, F., Jahn, H. & Wiedemann, K. A neuroendocrinological hypothesis on gender 
effects of naltrexone in relapse prevention treatment: Letter to the editor. 
Pharmacopsychiatry 38, 184–186 (2005). 
79. Bertholet, N., Winter, M. R., Cheng, D. M., Samet, J. H. & Saitz, R. How accurate are 
blood (or breath) tests for identifying self-reported heavy drinking among people with 
alcohol dependence? Alcohol Alcohol. 49, 423–429 (2014). 
80. Robinson, N., Kavanagh, D., Connor, J., May, J. & Andrade, J. Assessment of 
motivation to control alcohol use: The motivational thought frequency and state 
motivation scales for alcohol control. Addict. Behav. 59, 1–6 (2016). 
81. Tiffany, S. T., Friedman, L., Greenfield, S. F., Hasin, D. S. & Jackson, R. Beyond drug 
use: a systematic consideration of other outcomes in evaluations of treatments for 
substance use disorders. Addiction 107, 709–718 (2011). 
82. Nahum-Shani, I. et al. A SMART data analysis method for constructing adaptive 
treatment strategies for substance use disorders. Addiction 112, 901–909 (2017). 
Page 29 of 29 
 
83. Leggio, L. Understanding and treating alcohol craving and dependence: Recent 
pharmacological and neuroendocrinological findings. Alcohol Alcohol. 44, 341–352 
(2009). 
84. Marlatt, G. A. & Witkiewitz, K. Relapse prevention for alcohol and drug problems. in 
Relapse Prevention for Alcohol and Drug Problems (eds. Marlatt, G. A. & Donovan, 
D.) 1–44 (Guilford Press, 2005). 
85. Witkiewitz, K. et al. Mindfulness-based treatment to prevent addictive behavior 
relapse: Theoretical models and hypothesized mechanisms of change. Subst. Use 
Misuse 49, 513–24 (2014). 
 
